Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance

AIM: To evaluate the relationship between gene polymorphism (BclI, ER22/23EK, N363S) and the occurrence, progression and sensitivity to glucocorticoid of lacrimal gland benign lymphoepithelial lesion (LGBLEL). METHODS: Clinical peripheral blood samples of 52 LGBLEL patients and 10 normal volunteers...

Full description

Bibliographic Details
Main Authors: Xu-Juan Zhang, Peng-Xiang Zhao, Ming-Shen Ma, Hao Wu, Rui Liu, Hui Wang, Meng-Yu Liu, Fei Xie, Xue-Mei Ma
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2023-11-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://ies.ijo.cn/en_publish/2023/11/20231102.pdf
_version_ 1797650554230407168
author Xu-Juan Zhang
Peng-Xiang Zhao
Ming-Shen Ma
Hao Wu
Rui Liu
Hui Wang
Meng-Yu Liu
Fei Xie
Xue-Mei Ma
author_facet Xu-Juan Zhang
Peng-Xiang Zhao
Ming-Shen Ma
Hao Wu
Rui Liu
Hui Wang
Meng-Yu Liu
Fei Xie
Xue-Mei Ma
author_sort Xu-Juan Zhang
collection DOAJ
description AIM: To evaluate the relationship between gene polymorphism (BclI, ER22/23EK, N363S) and the occurrence, progression and sensitivity to glucocorticoid of lacrimal gland benign lymphoepithelial lesion (LGBLEL). METHODS: Clinical peripheral blood samples of 52 LGBLEL patients and 10 normal volunteers were collected for DNA extraction and polymerase chain reaction sequencing to analyze single nucleotide polymorphism (SNP) genotypes. The lacrimal tissues of LGBLEL were surgically removed and made into paraffin sections for subsequent hematoxylin-eosin (HE) and Masson staining analysis. The duration of disease and hormone use of LGBLEL patients from diagnosis to surgery were also analyzed. The Meta-analysis follows PRISMA guidelines to conducted a systematic review of human studies investigating the relationship between the NR3C1 BclI polymorphism and glucocorticoids (GCs) sensitivity. RESULTS: There was no association between ER22/23EK or N363S and the occurrence of LGBLEL or GCs sensitivity (P>0.05); BclI GC genotype was closely related to GCs resistance (P=0.03) as is the minor allele C (P=0.0017). The HE staining and Masson staining showed that the GC genotype of BclI remarkably slowed down the disease progression and reduced fibrosis (P<0.05), especially for GCs-dependent patients (P<0.0001). Meta-analysis showed that BclI was not significantly associated with GCs responsiveness. CONCLUSION: The LGBLEL patients who carry the NR3C1 BclI allele C may be more sensitive to GCs and associated with lower fibrosis and slower disease progression. The results may guide the clinical treatment strategy for the LGBLEL patients.
first_indexed 2024-03-11T16:02:02Z
format Article
id doaj.art-75e6a73c87684ea5a20a3c9fa0c7b4c7
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-03-11T16:02:02Z
publishDate 2023-11-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-75e6a73c87684ea5a20a3c9fa0c7b4c72023-10-25T06:50:11ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982023-11-0116111734174510.18240/ijo.2023.11.0220231102Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistanceXu-Juan Zhang0Peng-Xiang Zhao1Ming-Shen Ma2Hao Wu3Rui Liu4Hui Wang5Meng-Yu Liu6Fei Xie7Xue-Mei Ma8Peng-Xiang Zhao and Xue-Mei Ma. Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China. zpx@bjut.edu.cn; xmma@bjut.edu.cnFaculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; Beijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing 100124, ChinaBeijing Tongren Hospital, Capital Medical University, Beijing 100730, ChinaFaculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; Beijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing 100124, ChinaBeijing Tongren Hospital, Capital Medical University, Beijing 100730, ChinaFaculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; Beijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing 100124, China; State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi International Joint Research Center for Oral Diseases, Department of General Dentistry and Emergency, School of Stomatology, Air Force Medical UniversityFaculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; Beijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing 100124, ChinaFaculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; Beijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing 100124, ChinaFaculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; Beijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing 100124, ChinaAIM: To evaluate the relationship between gene polymorphism (BclI, ER22/23EK, N363S) and the occurrence, progression and sensitivity to glucocorticoid of lacrimal gland benign lymphoepithelial lesion (LGBLEL). METHODS: Clinical peripheral blood samples of 52 LGBLEL patients and 10 normal volunteers were collected for DNA extraction and polymerase chain reaction sequencing to analyze single nucleotide polymorphism (SNP) genotypes. The lacrimal tissues of LGBLEL were surgically removed and made into paraffin sections for subsequent hematoxylin-eosin (HE) and Masson staining analysis. The duration of disease and hormone use of LGBLEL patients from diagnosis to surgery were also analyzed. The Meta-analysis follows PRISMA guidelines to conducted a systematic review of human studies investigating the relationship between the NR3C1 BclI polymorphism and glucocorticoids (GCs) sensitivity. RESULTS: There was no association between ER22/23EK or N363S and the occurrence of LGBLEL or GCs sensitivity (P>0.05); BclI GC genotype was closely related to GCs resistance (P=0.03) as is the minor allele C (P=0.0017). The HE staining and Masson staining showed that the GC genotype of BclI remarkably slowed down the disease progression and reduced fibrosis (P<0.05), especially for GCs-dependent patients (P<0.0001). Meta-analysis showed that BclI was not significantly associated with GCs responsiveness. CONCLUSION: The LGBLEL patients who carry the NR3C1 BclI allele C may be more sensitive to GCs and associated with lower fibrosis and slower disease progression. The results may guide the clinical treatment strategy for the LGBLEL patients.http://ies.ijo.cn/en_publish/2023/11/20231102.pdflacrimal gland benign lymphoepithelial lesionbclisingle nucleotide polymorphismsglucocorticoids resistancefibrosis
spellingShingle Xu-Juan Zhang
Peng-Xiang Zhao
Ming-Shen Ma
Hao Wu
Rui Liu
Hui Wang
Meng-Yu Liu
Fei Xie
Xue-Mei Ma
Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
International Journal of Ophthalmology
lacrimal gland benign lymphoepithelial lesion
bcli
single nucleotide polymorphisms
glucocorticoids resistance
fibrosis
title Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
title_full Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
title_fullStr Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
title_full_unstemmed Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
title_short Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
title_sort association analysis of bcli with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance
topic lacrimal gland benign lymphoepithelial lesion
bcli
single nucleotide polymorphisms
glucocorticoids resistance
fibrosis
url http://ies.ijo.cn/en_publish/2023/11/20231102.pdf
work_keys_str_mv AT xujuanzhang associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT pengxiangzhao associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT mingshenma associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT haowu associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT ruiliu associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT huiwang associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT mengyuliu associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT feixie associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance
AT xuemeima associationanalysisofbcliwithbenignlymphoepitheliallesionsofthelacrimalglandandglucocorticoidsresistance